CareLit · DOI-Nachweis · Aktuelle Urologie
Intravesical BCG-Therapy for Superficial Bladder Cancer: Its Effectiveness and Adverse Effects
DOI 10.1055/s-2008-1055653
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH. Tanaka, J. Yoshimasa, Y. Furukawa, Y. Arai, T. Araki
ZeitschriftAktuelle Urologie
AusgabeS 1/1996
Jahrgang / SeitenJg. 27 · S. 51-53
Kernaussage aus der Literatur
Abstract-Vorschau
Summary: The aim of this investigation was to study the most significant complications of intravesical bacillus Calmette-Guérin (BCG) immunotherapy as well as the short-term effectiveness of the therapy on 174 patients with superficial transitional cell carcinoma of the bladder (Tis, Ta, or T1) treated in our hospitals. Six weekly instillations of 80 mg of BCG were given to 103 patients, six weekly and then four mon…
Zitieren
Zitierempfehlung
H. Tanaka, J. Yoshimasa, Y. Furukawa, Y. Arai, T. Araki (1996) Intravesical BCG-Therapy for Superficial Bladder Cancer: Its Effectiveness and Adverse Effects. Aktuelle Urologie, 27 (S 1), 51-53. https://doi.org/10.1055/s-2008-1055653
Mit CareLit weiterarbeiten